UBS Downgrades Johnson & Johnson (JNJ) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Cantor Fitzgerald Reiterates Overweight Rating on Johnson & Johnson (JNJ) Following Court Decision
April 28, 2020 6:53 AM EDTCantor Fitzgerald analyst Louise Chen reiterated an Overweight rating and $168.00 price target on Johnson & Johnson (NYSE: JNJ) following the courts much-anticipated Daubert decision, which Chen thinks turned out favorably for the company. The judge decided that certain plaintiff expert witnesses did not present... More
